Cargando…
Corrigendum to “The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on “Profibrotic Cytokine” IL-1β Levels in Severe and Critical COVID-19 Patients: A Preliminary Study”
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918366/ https://www.ncbi.nlm.nih.gov/pubmed/36776281 http://dx.doi.org/10.1155/2023/9846961 |
_version_ | 1784886593692106752 |
---|---|
author | Karina, Karina Martin Christoffel, Louis Novariani, Rita Rosadi, Imam Rosliana, Iis Rosidah, Siti Sobariah, Siti Fatkhurohman, Novy Puspitaningrum, Nurlaela Hertati, Yuli Afini, Irsyah Ernanda, Difky Widyastuti, Tias Sulaeha, A. D. Zakiyah, Alfida Aini, Noor Krisandi, Grady Andrew, Hubert |
author_facet | Karina, Karina Martin Christoffel, Louis Novariani, Rita Rosadi, Imam Rosliana, Iis Rosidah, Siti Sobariah, Siti Fatkhurohman, Novy Puspitaningrum, Nurlaela Hertati, Yuli Afini, Irsyah Ernanda, Difky Widyastuti, Tias Sulaeha, A. D. Zakiyah, Alfida Aini, Noor Krisandi, Grady Andrew, Hubert |
author_sort | Karina, Karina |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9918366 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-99183662023-02-11 Corrigendum to “The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on “Profibrotic Cytokine” IL-1β Levels in Severe and Critical COVID-19 Patients: A Preliminary Study” Karina, Karina Martin Christoffel, Louis Novariani, Rita Rosadi, Imam Rosliana, Iis Rosidah, Siti Sobariah, Siti Fatkhurohman, Novy Puspitaningrum, Nurlaela Hertati, Yuli Afini, Irsyah Ernanda, Difky Widyastuti, Tias Sulaeha, A. D. Zakiyah, Alfida Aini, Noor Krisandi, Grady Andrew, Hubert Scientifica (Cairo) Corrigendum Hindawi 2023-02-03 /pmc/articles/PMC9918366/ /pubmed/36776281 http://dx.doi.org/10.1155/2023/9846961 Text en Copyright © 2023 Karina Karina et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Corrigendum Karina, Karina Martin Christoffel, Louis Novariani, Rita Rosadi, Imam Rosliana, Iis Rosidah, Siti Sobariah, Siti Fatkhurohman, Novy Puspitaningrum, Nurlaela Hertati, Yuli Afini, Irsyah Ernanda, Difky Widyastuti, Tias Sulaeha, A. D. Zakiyah, Alfida Aini, Noor Krisandi, Grady Andrew, Hubert Corrigendum to “The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on “Profibrotic Cytokine” IL-1β Levels in Severe and Critical COVID-19 Patients: A Preliminary Study” |
title | Corrigendum to “The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on “Profibrotic Cytokine” IL-1β Levels in Severe and Critical COVID-19 Patients: A Preliminary Study” |
title_full | Corrigendum to “The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on “Profibrotic Cytokine” IL-1β Levels in Severe and Critical COVID-19 Patients: A Preliminary Study” |
title_fullStr | Corrigendum to “The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on “Profibrotic Cytokine” IL-1β Levels in Severe and Critical COVID-19 Patients: A Preliminary Study” |
title_full_unstemmed | Corrigendum to “The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on “Profibrotic Cytokine” IL-1β Levels in Severe and Critical COVID-19 Patients: A Preliminary Study” |
title_short | Corrigendum to “The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on “Profibrotic Cytokine” IL-1β Levels in Severe and Critical COVID-19 Patients: A Preliminary Study” |
title_sort | corrigendum to “the effect of intravenous autologous activated platelet-rich plasma therapy on “profibrotic cytokine” il-1β levels in severe and critical covid-19 patients: a preliminary study” |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918366/ https://www.ncbi.nlm.nih.gov/pubmed/36776281 http://dx.doi.org/10.1155/2023/9846961 |
work_keys_str_mv | AT karinakarina corrigendumtotheeffectofintravenousautologousactivatedplateletrichplasmatherapyonprofibroticcytokineil1blevelsinsevereandcriticalcovid19patientsapreliminarystudy AT martinchristoffellouis corrigendumtotheeffectofintravenousautologousactivatedplateletrichplasmatherapyonprofibroticcytokineil1blevelsinsevereandcriticalcovid19patientsapreliminarystudy AT novarianirita corrigendumtotheeffectofintravenousautologousactivatedplateletrichplasmatherapyonprofibroticcytokineil1blevelsinsevereandcriticalcovid19patientsapreliminarystudy AT rosadiimam corrigendumtotheeffectofintravenousautologousactivatedplateletrichplasmatherapyonprofibroticcytokineil1blevelsinsevereandcriticalcovid19patientsapreliminarystudy AT roslianaiis corrigendumtotheeffectofintravenousautologousactivatedplateletrichplasmatherapyonprofibroticcytokineil1blevelsinsevereandcriticalcovid19patientsapreliminarystudy AT rosidahsiti corrigendumtotheeffectofintravenousautologousactivatedplateletrichplasmatherapyonprofibroticcytokineil1blevelsinsevereandcriticalcovid19patientsapreliminarystudy AT sobariahsiti corrigendumtotheeffectofintravenousautologousactivatedplateletrichplasmatherapyonprofibroticcytokineil1blevelsinsevereandcriticalcovid19patientsapreliminarystudy AT fatkhurohmannovy corrigendumtotheeffectofintravenousautologousactivatedplateletrichplasmatherapyonprofibroticcytokineil1blevelsinsevereandcriticalcovid19patientsapreliminarystudy AT puspitaningrumnurlaela corrigendumtotheeffectofintravenousautologousactivatedplateletrichplasmatherapyonprofibroticcytokineil1blevelsinsevereandcriticalcovid19patientsapreliminarystudy AT hertatiyuli corrigendumtotheeffectofintravenousautologousactivatedplateletrichplasmatherapyonprofibroticcytokineil1blevelsinsevereandcriticalcovid19patientsapreliminarystudy AT afiniirsyah corrigendumtotheeffectofintravenousautologousactivatedplateletrichplasmatherapyonprofibroticcytokineil1blevelsinsevereandcriticalcovid19patientsapreliminarystudy AT ernandadifky corrigendumtotheeffectofintravenousautologousactivatedplateletrichplasmatherapyonprofibroticcytokineil1blevelsinsevereandcriticalcovid19patientsapreliminarystudy AT widyastutitias corrigendumtotheeffectofintravenousautologousactivatedplateletrichplasmatherapyonprofibroticcytokineil1blevelsinsevereandcriticalcovid19patientsapreliminarystudy AT sulaehaad corrigendumtotheeffectofintravenousautologousactivatedplateletrichplasmatherapyonprofibroticcytokineil1blevelsinsevereandcriticalcovid19patientsapreliminarystudy AT zakiyahalfida corrigendumtotheeffectofintravenousautologousactivatedplateletrichplasmatherapyonprofibroticcytokineil1blevelsinsevereandcriticalcovid19patientsapreliminarystudy AT aininoor corrigendumtotheeffectofintravenousautologousactivatedplateletrichplasmatherapyonprofibroticcytokineil1blevelsinsevereandcriticalcovid19patientsapreliminarystudy AT krisandigrady corrigendumtotheeffectofintravenousautologousactivatedplateletrichplasmatherapyonprofibroticcytokineil1blevelsinsevereandcriticalcovid19patientsapreliminarystudy AT andrewhubert corrigendumtotheeffectofintravenousautologousactivatedplateletrichplasmatherapyonprofibroticcytokineil1blevelsinsevereandcriticalcovid19patientsapreliminarystudy |